Vascular cell adhesion molecule-1: A viable therapeutic target for atherosclerosis?

International Journal of Clinical Practice

Volumn 61, Issue 4, 2007, Pages 697-701

  Preiss, D J ^a   Sattar, N ^b  

^a NHS Greater Glasgow and Clyde Clinical Biochemistry Service   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CELL ADHESION MOLECULE; CYCLOOXYGENASE 2 INHIBITOR; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR; PLACEBO; PROBUCOL; PROBUCOL SUCCINATE; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; CYTOKINE RELEASE; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; HUMAN; INFLAMMATION; INFLAMMATORY CELL; MONOTHERAPY; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANTIOXIDANTS; ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; EVIDENCE-BASED MEDICINE; GENE EXPRESSION REGULATION; HUMANS; PROBUCOL; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33947354929     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01330.x     Document Type: Review

References (27)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
2. Petruzzelli L, Takami M, Humes HD. Structure and function of cell adhesion molecules. Am J Med 1999; 106: 467-76.
3. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-34.
4. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 1992; 258: 964-9.
5. Adams DH, Shaw S. Leucocyte endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343: 831-6.
6. Shattil SJ, Ginsberg MH. Perspective series: cell adhesion in vascular biology. J Clin Invest 1997; 100: 1-5.
7. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U, Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1 beta. Nature 1993; 361: 79-82.
8. Furie MB, Tancinco MC, Smith CW. Monoclonal antibodies to leucocyte integrins CD11a/CD18 and CD11b/CD18 or intercellular adhesion molecule-1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood 1991; 78: 2089-97.
9. O'Brien KD, Allen MD, McDonald TO et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993; 92: 945-51.
10. Braun M, Pietsch P, Schror K, Baumann G, Felix SB. Cellular adhesion molecules on vascular smooth muscle cells. Cardiovasc Res 1999; 41: 395-401.
11. Hope SA, Meredith IT. Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction. Intern Med J 2003; 33: 450-62.
12. Malik I, Danesh J, Whincup P et al. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 2001; 358: 971-6.
13. Chen C, Mobley JL, Dwir O et al. High affinity very late antigen-4 subsets expressed on T cells are mandatory for spontaneous adhesion strengthening but not for rolling on VCAM-1 in shear flow. J Immunol 1999; 162: 1084-95.
14. Huo Y, Hafezi-Moghadam A, Ley K. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ Res 2000; 87: 153-9.
15. Cybulsky MI, Iiyama K, Li H et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001; 107: 1255-62.
16. Zhu Y, Liao HL, Lin JH, Verna L, Stemerman MB. Low-density lipoprotein augments interleukin-1 induced vascular adhesion molecule expression in human endothelial cells. Atherosclerosis 1999; 144: 357-65.
17. Esposito C, Fasoli G, Plati AR et al. Longterm exposure to high glucose upregulates VCAM-induced endothelial cell adhesiveness to PBMC. Kidney Int 2001; 59: 1842-9.
18. Rasmussen LM, Hansen PR, Nabipour MT, Olesen P, Kristiansen MT, Ledet T. Diverse effects of inhibition of 3-hydroxy-3 methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells. Biochem J 2001; 360: 363-70.
19. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappa B activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 2000; 20: 645-51.
20. Tardif JC, Cote G, Lesperance J et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997; 337: 365-72.
21. Walldius G, Erikson U, Olsson AG et al. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol 1994; 74: 875-83.
22. Rinninger F, Wang N, Ramakrishnan R et al. Probucol enhances selective uptake of HDL-associated cholesteryl esters in vitro by a scavenger receptor B-1 dependent mechanism. Arterioscler Thromb Vasc Biol 1999; 99: 30-5.
23. Tardif JC, Gregoire J, Schwartz L et al. Canadian Antioxidant Restenosis Trial (CART-1) Investigators. Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation 2003; 107: 552-8.
24. Reinoehl J, Frankovich D, Machado C et al. Probucol-associated tachyarrhythmic events and QT prolongation: importance of gender. Am Heart J 1996; 131: 1184-91.
25. Tardif JC, Gregoire J, L'allier PL et al. Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial. Atherosclerosis 2007 (in press).
26. Besemer J, Harant H, Wang S et al. Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1. Nature 2005; 436: 290-3.
27. Meng CQ, Somers PK, Rachita CL et al. Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis. Bioorg Med Chem Lett 2002; 12: 2545-8.